Every SEC Form 3/4/5 on record for this filer (CIK 1553595) — 1 issuer, 44 transactions. Section-16 filings only: what they filed, not a biography, and titles are as filed on their latest form at each issuer.
| Ticker | Company | Role as filed | On file | Forms | Open-market net |
|---|---|---|---|---|---|
| XERS | Xeris Biopharma Holdings, Inc. | See Remarks · Director | 2018-06-20 → 2026-02-02 | 27 | $63,669 |
| Ticker | Date | Action | Shares | Price | Value | Held after |
|---|---|---|---|---|---|---|
| XERS | 2026-01-05 | Sell | 24,907 | $7.08 | $176,342 | 2,705,346 |
| XERS | 2025-11-13 | Sell | 23,242 | $7.46 | $173,385 | 2,643,153 |
1 of 1 issuers are covered and open a security page; the rest are on file here only.